Summary

Quantification of DS-8201a and its pharmacokinetics in mouse plasma using Gyrolab LBA/ELISA

This case study demonstrates the successful quantification of the novel antibody-drug conjugate DS-8201a (T-DXd) in mouse plasma using Gyrolab LBA/ELISA—an advanced automated immunoassay platform. Witness how minimal plasma volumes enabled robust PK profiling—delivering high-precision data consistent with established literature.

Key Highlights

  • Efficient Workflow: Serial blood sampling from just 3 mice generated a complete 28-day PK profile.
  • Platform Power: Gyrolab® technology delivered sensitive quantification of total antibody and ADC.
  • Real-World Validation: Results confirmed DS-8201a' s slow elimination and favorable PK properties in vivo.

Download now to see how streamlined bioanalysis can transform your PK studies!

Fill in your data to download the case study

Back to overview